Addus HomeCare Co. (NASDAQ:ADUS) Receives $131.63 Consensus Price Target from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $131.63.

ADUS has been the subject of several analyst reports. Macquarie reiterated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Stephens boosted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer raised their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Finally, TD Cowen lifted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $122.07 on Tuesday. The firm’s 50-day simple moving average is $129.12 and its 200 day simple moving average is $122.06. The stock has a market cap of $2.21 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 2.20 and a beta of 1.04. Addus HomeCare has a fifty-two week low of $85.43 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the prior year, the firm posted $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. On average, sell-side analysts predict that Addus HomeCare will post 4.58 EPS for the current year.

Insider Buying and Selling

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,917 shares of company stock valued at $3,050,082. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares in the last quarter. Wasatch Advisors LP boosted its stake in Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after buying an additional 110,010 shares during the period. Point72 Asset Management L.P. grew its position in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.